hsa-mir-4659a-3p _LIHC.png
hsa-mir-892b _LIHC.png
hsa-mir-130b-3p _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10019680
Fusion event
HBV-AGO1 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1832
Integrated sequence
TGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCT| |CTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACCCTTATAAAGAATTTGGA
Host Sequence
Chromosome
chr1
Cytoband
p34.3
Reference genome
End
36339715/35874114 (Hg38)
Location type
Intron1
Target gene
miRNAs that regulate target gene
hsa-mir-503-5p ; hsa-mir-148b-3p ; hsa-mir-130b-3p ; hsa-mir-106b-5p ; hsa-mir-107 ; hsa-mir-93-5p ; hsa-mir-19b-3p ; hsa-mir-320c ; hsa-mir-877-3p ; hsa-mir-877-5p ; hsa-mir-744-5p ; hsa-mir-455-3p ; hsa-mir-151a-5p ; hsa-mir-93-3p ; hsa-mir-769-3p ; hsa-mir-421 ; hsa-mir-652-3p ; hsa-mir-628-3p ; hsa-mir-615-3p ; hsa-mir-18a-3p ; hsa-mir-193b-3p ; hsa-mir-146b-5p ; hsa-mir-484 ; hsa-mir-423-3p ; hsa-mir-324-5p ; hsa-mir-326 ; hsa-mir-328-3p ; hsa-mir-330-3p ; hsa-mir-378a-3p ; hsa-mir-320a ; hsa-mir-195-5p ; hsa-mir-194-5p ; hsa-mir-186-5p ; hsa-mir-185-5p ; hsa-mir-149-5p ; hsa-mir-138-5p ; hsa-let-7g-5p ; hsa-mir-212-3p ; hsa-mir-34a-5p ; hsa-mir-30d-5p ; hsa-mir-30c-5p ; hsa-mir-197-3p ; hsa-mir-106a-5p ; hsa-mir-99a-5p ; hsa-mir-92a-3p ; hsa-mir-31-5p ; hsa-mir-29a-3p ; hsa-mir-26a-5p ; hsa-mir-25-3p ; hsa-mir-20a-5p ; hsa-mir-17-5p ; hsa-let-7e-5p ; hsa-let-7c-5p ; hsa-let-7b-5p ; hsa-let-7a-5p ; hsa-mir-3678-3p ; hsa-mir-4779 ; hsa-mir-2467-3p ; hsa-mir-19a-3p ; hsa-mir-20b-5p ; hsa-mir-519d-3p ; hsa-mir-103a-3p ; hsa-let-7d-5p ; hsa-let-7f-5p ; hsa-let-7i-5p ; hsa-mir-1-3p ; hsa-mir-6734-5p ; hsa-mir-1226-5p ; hsa-mir-6834-5p ; hsa-mir-4684-5p ; hsa-mir-4721 ; hsa-mir-3616-3p ; hsa-mir-942-5p ; hsa-mir-1251-5p ; hsa-mir-517-5p ; hsa-mir-325 ; hsa-mir-7843-5p ; hsa-mir-6879-5p ; hsa-mir-4632-5p ; hsa-mir-6735-5p ; hsa-mir-4436b-3p ; hsa-mir-100-3p ; hsa-mir-3166 ; hsa-mir-4756-3p ; hsa-mir-1324 ; hsa-mir-449c-5p ; hsa-mir-34b-5p ; hsa-mir-2682-5p ; hsa-mir-940 ; hsa-mir-6893-5p ; hsa-mir-6808-5p ; hsa-mir-6511a-5p ; hsa-mir-1910-3p ; hsa-mir-8075 ; hsa-mir-219a-2-3p ; hsa-mir-218-5p ; hsa-mir-4266 ; hsa-mir-4717-5p ; hsa-mir-3919 ; hsa-mir-4695-5p ; hsa-mir-6510-5p ; hsa-mir-4690-5p ; hsa-mir-6165 ; hsa-mir-4659b-3p ; hsa-mir-4659a-3p ; hsa-mir-6875-3p ; hsa-mir-4279 ; hsa-mir-4777-3p ; hsa-mir-6511b-3p ; hsa-mir-6511a-3p ; hsa-mir-892b ; hsa-mir-4514 ; hsa-mir-4524b-3p ; hsa-mir-4692
Nearest miRNA
hsa-mir-12136/Upstream/1204420; hsa-mir-101-1/Downstream/1287449;
Upstream sequence
NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNt
Downstream sequence
TTATTTAAGAAAATTAACGTAGATATTAAAGTTAACATTATCTTTTTCTCAGTACCATAAATTTTTCCTATCTGTTCTAGCTTAAGGACAGAAATTATAC
Reference
Cancer Genome Atlas Research Network. Electronic address, w. b. e. and N. Cancer Genome Atlas Research . Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell ,2017,169(7): 1327-1341 e13
Curate